|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.54 - 1.64|
|52 Week Range||1.38 - 4.29|
|PE Ratio (TTM)||10.95|
|Earnings Date||Sep 20, 2017 - Sep 25, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
Rite Aid Corporation today announced that it has commenced an offer to purchase for cash up to $700,000,000 of certain of its outstanding indebtedness, consisting of its 6.75% Senior Notes due 2021 and 6.125% Senior Notes due 2023 , with a portion of the net cash proceeds received from its previously announced sale to Walgreens Boots Alliance, Inc.
Rite Aid Corporation (RAD) announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is available at each of the more than 2,500 Rite Aid pharmacies in the United States and can be dispensed without a prescription, subject to state regulations. “The opioid epidemic has reached epic proportions and it is an issue that demands not only our attention but also our continued action to help reduce the rise in opioid deaths,” said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. “For the past two years, we’ve worked with state and federal lawmakers to increase access to this life-saving medication.
Moody's Investors Service, ("Moody's") today assigned a B1 Corporate Family Rating and B1-PD probability of default rating to Albertsons Companies, Inc. ("Albertsons"). Moody's also ...
Rite Aid’s (RAD) management provided guidance for fiscal 2019 in its fiscal 4Q18 report. Management believes the company will benefit from generic drug purchasing efficiencies, a more stable reimbursement rate environment, Walgreens’s deal-related TSA (Transportation Security Administration) fees, and the company’s ongoing initiatives in fiscal 2019.
As we saw in the previous part of this series, Rite Aid (RAD) reported an 8.6% YoY (year-over-year) decline in its fiscal 4Q18 revenues from continuing operations to $5.4 billion. Its Retail Pharmacy segment, which includes prescription drugs, health and beauty products, and personal care items, saw its revenue fall 10.1% to $4 billion. Same-store sales from continuing operations fell 1.7% YoY during the quarter, driven by a 2.3% decline in pharmacy sales and a 0.6% fall in front-end sales.
Rite Aid (RAD) reported its fiscal 4Q18 results after the market closed on Thursday, April 12, 2018. Its top line fell 8.6% YoY (year-over-year) to $5.4 billion, missing the average consensus expectation by $180 million.
CVS (CVS), which is an American retail pharmacy and healthcare company, was the S&P 500’s second-highest performer on April 16. After gaining for three consecutive trading days, CVS opened higher on Monday and surged to four-week high price levels.
On Thursday, April 12, 2018, Rite Aid (RAD) reported its results for fiscal 4Q18 and fiscal 2018. The results relate to the three-month and 12-month period that ended March 3, 2018.
NEW YORK, NY / ACCESSWIRE / April 17, 2018 / Shares of Walgreens and Rite Aid saw gains on Monday after reports emerged that Amazon has shelved its plans to sell prescription drugs to doctors and hospitals. ...
NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Despite the threat of Amazon entering the pharmacy business, Walgreens, CVS and Rite Aid see corner locations and bricks and mortar expansions as a consumer's entry point for health access.
Rite Aid (RAD) reports better-than-expected bottom-line results for fourth-quarter fiscal 2018, while sales disappoint. Improvement in reimbursement rates aid results.
Rite Aid sees a future to grow its EnvisionRx pharmacy benefit manager selling services to “mid-sized” companies and employer clients.
Some Rite Aid Corp. shareholders plan to oppose a merger with grocer Albertsons Cos. that they believe undervalues the struggling pharmacy chain. Rite Aid’s shares have fallen about 20% since the companies said they would merge on Feb. 20, a sign of deepening investor disapproval. Albertsons is closely held.
Here are a few highlights from Rite Aid Corporation’s most recent earnings report. The company reported losses per share of one penny for its fiscal fourth quarter of 2018. This is a drop from its earnings per share of 2 cents from the same time last year.
Rite Aid will escalate the conversion of its pharmacies to "wellness stores" and will also look at new freestanding stores once its deal with grocer Albertsons closes later this year.
Drug retailer Rite Aid Corp on Thursday forecast a full-year profit largely above estimates as it expects reimbursement rates to rise this year and its deal with Walgreens to help it secure better generic drug prices. Rite Aid sold half of its stores to Walgreens Boots Alliance Inc last year after Walgreens' bid to buy the whole company collapsed due to antitrust concerns. The much smaller Rite Aid then agreed to be bought by U.S. grocer Albertsons Cos Inc, hoping to still remain a formidable player in the sector.
Yahoo Finance's Jared Blikre joins Seana Smith live from the New York Stock Exchange to discus the latest market moves.
Former House Speaker John Boehner has signed on as an advisor to a cannabis company. Yahoo Finance’s Alexis Christoforous, Acreage Holdings CEO Kevin Murphy, and former Massachusetts Governor William Weld discuss how the industry is changing with increased support from government leaders.
Rite Aid, Disney, Fox, Tesla and Apple are the companies to watch.